900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Product containing only vinblastine (medicinal product)	Preferred (foundation metadata concept)
Product containing only vincristine (medicinal product)	Preferred (foundation metadata concept)
Product containing only vinorelbine (medicinal product)	Preferred (foundation metadata concept)
Product containing only voriconazole (medicinal product)	Preferred (foundation metadata concept)
Product containing only warfarin (medicinal product)	Preferred (foundation metadata concept)
Product containing only xylometazoline (medicinal product)	Preferred (foundation metadata concept)
Product containing only zidovudine (medicinal product)	Preferred (foundation metadata concept)
Product containing only zinc sulfate (medicinal product)	Preferred (foundation metadata concept)
Product containing only zoledronic acid (medicinal product)	Preferred (foundation metadata concept)
Product containing pancreatic enzyme (product)	Preferred (foundation metadata concept)
Product containing precisely Podophyllum resin 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely abacavir (as abacavir sulfate) 120 milligram and lamivudine 60 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely abacavir (as abacavir sulfate) 300 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely abacavir (as abacavir sulfate) 60 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely abiraterone acetate 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely abiraterone acetate 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely acenocoumarol 1 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely acetazolamide 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely acetic acid 20 milligram/1 milliliter conventional release ear solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely acetylcysteine 100 milligram/1 milliliter conventional release solution for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely acetylcysteine 200 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aciclovir (as aciclovir sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aciclovir 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aciclovir 30 milligram/1 gram conventional release eye ointment (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aciclovir 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely activated charcoal 200 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely activated charcoal 208.333 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely activated charcoal 813 milligram/1 gram granules for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely adalimumab 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely albendazole 400 milligram/1 each conventional release chewable tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely allopurinol 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely alprostadil 10 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely alteplase 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely alteplase 20 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely alteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amikacin (as amikacin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amikacin sulfate 10 milligram/1 milliliter conventional release eye drops (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amiloride hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amiodarone hydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amiodarone hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amiodarone hydrochloride 400 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amiodarone hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amitriptyline hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amitriptyline hydrochloride 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amitriptyline hydrochloride 75 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and telmisartan 80 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and lisinopril 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and lisinopril 20 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and telmisartan 40 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and telmisartan 80 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amlodipine (as amlodipine maleate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amlodipine (as amlodipine mesilate) 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 135 milligram and artesunate 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 153 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 270 milligram and artesunate 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 67.5 milligram and artesunate 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amodiaquine (as amodiaquine hydrochloride) 76.5 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin (as amoxicillin sodium) 1 gram and clavulanic acid (as clavulanate potassium) 200 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin (as amoxicillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin (as amoxicillin sodium) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin 500 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amphotericin B 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amphotericin B liposome 50 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ampicillin (as ampicillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ampicillin (as ampicillin sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely anastrozole 1 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aprepitant 125 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aprepitant 125 milligram/1 sachet powder for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aprepitant 165 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aprepitant 80 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely arsenic trioxide 1 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artemether 20 milligram and lumefantrine 120 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artemether 80 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artenimol 20 milligram and piperaquine phosphate 160 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artenimol 40 milligram and piperaquine phosphate 320 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artesunate 100 milligram and mefloquine hydrochloride 220 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artesunate 100 milligram/1 each conventional release rectal suppository (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artesunate 20 milligram and pyronaridine tetraphosphate 60 milligram/1 sachet granules for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artesunate 25 milligram and mefloquine (as mefloquine hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artesunate 60 milligram and pyronaridine tetraphosphate 180 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely artesunate 60 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely ascorbic acid 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely asparaginase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely aspirin 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)

Start Previous Page 404 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)